"Global Pneumonia Vaccine Market Overview:
Global Pneumonia Vaccine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Pneumonia Vaccine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Pneumonia Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Pneumonia Vaccine Market:
The Pneumonia Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Pneumonia Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Pneumonia Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Pneumonia Vaccine market has been segmented into:
Pneumococcal Conjugate
Pneumococcal Polysaccharide
By Application, Pneumonia Vaccine market has been segmented into:
Prevnar 13
Synflorix
Pneumovax 23
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Pneumonia Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Pneumonia Vaccine market.
Top Key Players Covered in Pneumonia Vaccine market are:
Pfizer Inc.Merck & Co. Inc.GlaxoSmithKline plcAstraZeneca plcSanofi PasteurSerum Institute of India Pvt Ltd.Abbott LaboratoriesF.Hoffmann-La Roche Ltd.CSL LimitedBharat Biotech International LimitedIncheon Vaccine Ltd.Beijing Minhai Biotechnology Co. Ltd.Lanzhou Institute of Biological Products Co. Ltd.Walvax Biotechnology Co. Ltd.Xiamen Innovax Biotech Co. Ltd.Dynavax Technologies CorporationHirom Abbiotec Co. Ltd.VaxiBio Inc.Imugene Limited
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Pneumonia Vaccine Market by Type
4.1 Pneumonia Vaccine Market Snapshot and Growth Engine
4.2 Pneumonia Vaccine Market Overview
4.3 Pneumococcal Conjugate
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Pneumococcal Conjugate: Geographic Segmentation Analysis
4.4 Pneumococcal Polysaccharide
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Pneumococcal Polysaccharide: Geographic Segmentation Analysis
Chapter 5: Pneumonia Vaccine Market by Application
5.1 Pneumonia Vaccine Market Snapshot and Growth Engine
5.2 Pneumonia Vaccine Market Overview
5.3 Prevnar 13
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Prevnar 13: Geographic Segmentation Analysis
5.4 Synflorix
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Synflorix: Geographic Segmentation Analysis
5.5 Pneumovax 23
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Pneumovax 23: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Pneumonia Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PFIZER INC.MERCK & CO. INC.GLAXOSMITHKLINE PLCASTRAZENECA PLCSANOFI PASTEURSERUM INSTITUTE OF INDIA PVT LTD.ABBOTT LABORATORIESF.HOFFMANN-LA ROCHE LTD.CSL LIMITEDBHARAT BIOTECH INTERNATIONAL LIMITEDINCHEON VACCINE LTD.BEIJING MINHAI BIOTECHNOLOGY CO. LTD.LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD.WALVAX BIOTECHNOLOGY CO. LTD.XIAMEN INNOVAX BIOTECH CO. LTD.DYNAVAX TECHNOLOGIES CORPORATIONHIROM ABBIOTEC CO. LTD.VAXIBIO INC.IMUGENE LIMITED
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
Chapter 7: Global Pneumonia Vaccine Market By Region
7.1 Overview
7.2. North America Pneumonia Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Pneumococcal Conjugate
7.2.4.2 Pneumococcal Polysaccharide
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Prevnar 13
7.2.5.2 Synflorix
7.2.5.3 Pneumovax 23
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Pneumonia Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Pneumococcal Conjugate
7.3.4.2 Pneumococcal Polysaccharide
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Prevnar 13
7.3.5.2 Synflorix
7.3.5.3 Pneumovax 23
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Pneumonia Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Pneumococcal Conjugate
7.4.4.2 Pneumococcal Polysaccharide
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Prevnar 13
7.4.5.2 Synflorix
7.4.5.3 Pneumovax 23
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Pneumonia Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Pneumococcal Conjugate
7.5.4.2 Pneumococcal Polysaccharide
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Prevnar 13
7.5.5.2 Synflorix
7.5.5.3 Pneumovax 23
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Pneumonia Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Pneumococcal Conjugate
7.6.4.2 Pneumococcal Polysaccharide
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Prevnar 13
7.6.5.2 Synflorix
7.6.5.3 Pneumovax 23
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Pneumonia Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Pneumococcal Conjugate
7.7.4.2 Pneumococcal Polysaccharide
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Prevnar 13
7.7.5.2 Synflorix
7.7.5.3 Pneumovax 23
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Pneumonia Vaccine Scope:
|
Report Data
|
Pneumonia Vaccine Market
|
|
Pneumonia Vaccine Market Size in 2025
|
USD XX million
|
|
Pneumonia Vaccine CAGR 2025 - 2032
|
XX%
|
|
Pneumonia Vaccine Base Year
|
2024
|
|
Pneumonia Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pfizer Inc.Merck & Co. Inc.GlaxoSmithKline plcAstraZeneca plcSanofi PasteurSerum Institute of India Pvt Ltd.Abbott LaboratoriesF.Hoffmann-La Roche Ltd.CSL LimitedBharat Biotech International LimitedIncheon Vaccine Ltd.Beijing Minhai Biotechnology Co. Ltd.Lanzhou Institute of Biological Products Co. Ltd.Walvax Biotechnology Co. Ltd.Xiamen Innovax Biotech Co. Ltd.Dynavax Technologies CorporationHirom Abbiotec Co. Ltd.VaxiBio Inc.Imugene Limited.
|
|
Key Segments
|
By Type
Pneumococcal Conjugate
Pneumococcal Polysaccharide
By Applications
Prevnar 13
Synflorix
Pneumovax 23
|
